CELLDEX THERAPEUTICS, Inc. (CLDX) Misses Q3 EPS by 1c

CELLDEX THERAPEUTICS, Inc. (NASDAQ: CLDX) reported Q3 EPS of ($0.27), $0.01 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $2.36 million versus the consensus estimate of $2.01 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Guggenheim flags this biotech stocks as one of its top picks
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• Kroger meets earnings expectations, revenue tops estimates